A yellow fever outbreak in Colombia is behaving in ways that have alarmed global health officials — with a case fatality rate that in several reporting periods has exceeded 40 to 70 percent, far above the typical 10 to 30 percent historical mortality rate for this viral hemorrhagic fever. Since the outbreak began in late 2024, a total of 168 confirmed cases and 76 deaths have been reported across Colombia, spanning at least 10 departments including Tolima, Caldas, Caquetá, Cauca, Guaviare, Huila, Meta, Nariño, Putumayo, and Vaupés. In 2026 alone, 35 confirmed cases and 18 deaths were reported through early April.
The Department of Tolima has become the epicenter — historically a low-risk zone that had not experienced significant yellow fever activity in the modern vaccination era. Colombia administered nearly 5 million yellow fever vaccine doses between September 2024 and January 2026, but persistent gaps in adult vaccination coverage — particularly among rural workers and communities that expanded into previously forested areas where the Aedes and Haemagogus mosquito vectors are present — continue to drive cases.
The CDC maintains an active Level 2 Travel Health Notice for yellow fever in South America — "Practice Enhanced Precautions" — covering Colombia, Bolivia, Brazil, and Peru, noting that cases have occurred in new areas bordering regions where vaccination has historically been recommended. Travelers to newly affected areas are now specifically recommended to receive vaccination. Venezuela has a separately documented yellow fever outbreak declared in a CDC Travel Notice issued March 16, 2026, adding a second country in northern South America to the active alert list.
Why the Mortality Rate Is So High
The extraordinarily high case fatality rate observed in the Colombia outbreak demands examination. Several factors contribute. First, all documented cases have been in unvaccinated individuals — and yellow fever in unvaccinated adults tends to produce more severe disease than in previously exposed populations. Second, Colombian health officials noted that 78 epizootics — yellow fever outbreaks in non-human primates — were recorded between 2025 and January 2026 in areas adjacent to human communities, indicating intense, active viral circulation in the local ecosystem rather than sporadic importation events.
Third, clinical access in the affected departments is limited. Tolima and the other heavily affected regions are characterized by warm climates, fragmented forest landscapes, and communities with limited proximity to hospitals equipped to manage yellow fever's most severe manifestations: hemorrhagic fever, multi-organ failure, and the paradoxical clinical worsening that occurs when the immune system over-responds to the virus. A December 2025 CDC Emerging Infectious Diseases publication confirmed the reemergence of yellow fever virus in the Magdalena Valley and called for immediate comprehensive measures including mass vaccination, genomic surveillance, and integrated One Health frameworks.
What the Yellow Fever Vaccine Is and Why Travelers Must Get It Before Departure
Yellow fever is caused by a flavivirus transmitted by infected Aedes and Haemagogus mosquitoes. It cannot spread from person to person. The disease produces a spectrum of illness from mild febrile illness to severe hemorrhagic fever with jaundice — giving the disease its name — multi-organ failure, and death. There is no specific antiviral treatment; management is entirely supportive.
The yellow fever vaccine (YF-Vax) is one of the most effective vaccines ever developed — a single dose provides lifelong immunity in 99 percent of recipients. No booster is required for most travelers under current WHO and CDC guidelines. The vaccine must be administered at least 10 days before travel to be fully protective, and it must be given at a CDC-designated yellow fever vaccine provider — not all clinics carry it.
Travelers to Colombia, Venezuela, Bolivia, Peru, and any country on the CDC's Level 2 yellow fever notice should receive yellow fever vaccination before departure. Some countries require proof of vaccination (an International Certificate of Vaccination) for entry. Even countries that do not require the certificate as a condition of entry may require it if a traveler is coming from a country with active yellow fever transmission.
Frequently Asked Questions
Q: How serious is the yellow fever outbreak in Colombia?
A: 168 confirmed cases and 76 deaths since 2024, with case fatality rates exceeding 40–70% in some reporting periods. In 2026 alone, 35 cases and 18 deaths have been confirmed through early April. All cases have been in unvaccinated individuals.
Q: Is there also yellow fever in Venezuela?
A: Yes. The CDC issued a travel notice for yellow fever in Venezuela in March 2026, covering an active outbreak across multiple regions.
Q: What does the CDC's Level 2 Travel Notice for yellow fever mean?
A: Level 2 means "Practice Enhanced Precautions." Travelers should ensure they are vaccinated against yellow fever before visiting affected areas. The notice currently covers Colombia, Bolivia, Brazil, and Peru.
Q: How effective is the yellow fever vaccine?
A: Extremely effective — a single dose provides lifelong immunity in 99% of recipients. No booster is required for most travelers. The vaccine must be received at a CDC-designated provider at least 10 days before travel.
Q: Can yellow fever be treated?
A: No specific antiviral treatment exists. Management is supportive. Prevention through vaccination is the only reliable protection.
